CDK11 requires a critical activator SAP30BP to regulate pre-mRNA splicing

Changshou Wang1, Lin Xu1, Chen Du2

  • 1Key Laboratory of RNA Science and Engineering, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China.

The EMBO Journal
|December 7, 2023
PubMed

Insights

SAP30BP is identified as a crucial activator for CDK11 (cyclin-dependent kinase 11), a key target in cancer therapy. This interaction is vital for regulating pre-mRNA splicing, impacting cell cycle progression in cancer cells.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Biochemistry

Background:

  • CDK11 (cyclin-dependent kinase 11) is a promising target for cancer therapy due to its roles in cell cycle progression and phosphorylation of transcription/splicing factors.
  • CDK11 activation requires cyclin L1 or L2, but other regulatory mechanisms remain largely unknown.

Purpose of the Study:

  • To investigate novel regulators of CDK11 activity.
  • To elucidate the role of SAP30BP in CDK11 function and its impact on pre-mRNA splicing.

Main Methods:

  • Co-immunoprecipitation to study protein complex formation.
  • In vitro kinase assays to assess CDK11 activity.
  • In vivo degradation studies to evaluate protein stability and function.
  • Analysis of pre-mRNA splicing defects.

Main Results:

  • SAP30BP forms a stable complex with CDK11 and cyclins L1/L2.
  • SAP30BP degradation leads to defects in pre-mRNA splicing, similar to CDK11 loss.
  • SAP30BP enhances CDK11 kinase activity by stabilizing cyclin L1/L2 association with CDK11.
  • SAP30BP is essential for maintaining global pre-mRNA splicing.

Conclusions:

  • SAP30BP is identified as a critical activator of CDK11.
  • SAP30BP plays a vital role in regulating global pre-mRNA splicing through CDK11 modulation.
  • These findings highlight SAP30BP as a potential therapeutic target in conjunction with CDK11 for cancer treatment.

Related Concept Videos

RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.4K
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.2K
Chromatin Structure Regulates pre-mRNA Processing02:41

Chromatin Structure Regulates pre-mRNA Processing

In eukaryotic cells, nascent mRNA transcripts need to undergo many post-transcriptional modifications to reach the cell cytoplasm and translate into functional proteins. For a long time, transcription and pre-mRNA processing were considered two independent events that occur sequentially in the cell. However, it has now been well established that transcription and pre-mRNA processing are two simultaneous processes that are precisely regulated inside the cell.
The chromatin structure, especially...
7.0K
Pre-mRNA Processing: RNA Splicing01:36

Pre-mRNA Processing: RNA Splicing

5.2K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.9K